Obalon Therapeutics, Inc. carries a market capitalization of 5.47M, placing it among publicly traded companies globally.
| Market Cap | 5.47M |
| Enterprise Value | N/A |
Obalon Therapeutics, Inc.'s stock has gained approximately 152.06612% over the past 52 weeks. The 50-day moving average sits at 9.07, while the 200-day moving average is 9.08.
| Beta (5Y) | N/A |
| 52-Week Price Change | 152.06612% |
| 50-Day Moving Average | 9.07 |
| 200-Day Moving Average | 9.08 |
| Average Volume (20 Days) | N/A |
Obalon Therapeutics, Inc.'s most recent stock split took place on June 16, 2021 with a 3:1 split ratio.
| Last Split Date | 6/16/2021 |
| Split Ratio | 3:1 |